vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and IonQ, Inc. (IONQ). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $61.9M, roughly 1.0× IonQ, Inc.). IonQ, Inc. runs the higher net margin — 1217.8% vs -70.9%, a 1288.7% gap on every dollar of revenue. On growth, IonQ, Inc. posted the faster year-over-year revenue change (428.5% vs 8.1%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-83.3M).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
IonQ, Inc. is an American quantum computing hardware and software company headquartered in College Park, Maryland. The company develops general-purpose trapped ion quantum computers and accompanying software to generate, optimize, and execute quantum circuits.
CTKB vs IONQ — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $61.9M |
| Net Profit | $-44.1M | $753.7M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | -369.4% |
| Net Margin | -70.9% | 1217.8% |
| Revenue YoY | 8.1% | 428.5% |
| Net Profit YoY | -557.1% | 473.1% |
| EPS (diluted) | — | $2.60 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $61.9M | ||
| Q3 25 | $52.3M | $39.9M | ||
| Q2 25 | $45.6M | $20.7M | ||
| Q1 25 | $41.5M | — | ||
| Q4 24 | $57.5M | $11.7M | ||
| Q3 24 | $51.5M | $12.4M | ||
| Q2 24 | $46.6M | $11.4M | ||
| Q1 24 | $44.9M | — |
| Q4 25 | $-44.1M | $753.7M | ||
| Q3 25 | $-5.5M | $-1.1B | ||
| Q2 25 | $-5.6M | $-176.8M | ||
| Q1 25 | $-11.4M | — | ||
| Q4 24 | $9.6M | $-202.0M | ||
| Q3 24 | $941.0K | $-52.5M | ||
| Q2 24 | $-10.4M | $-37.6M | ||
| Q1 24 | $-6.2M | — |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | -369.4% | ||
| Q3 25 | -17.6% | -423.5% | ||
| Q2 25 | -23.3% | -776.0% | ||
| Q1 25 | -36.1% | — | ||
| Q4 24 | 5.2% | -661.9% | ||
| Q3 24 | -8.2% | -428.5% | ||
| Q2 24 | -18.3% | -430.0% | ||
| Q1 24 | -23.9% | — |
| Q4 25 | -70.9% | 1217.8% | ||
| Q3 25 | -10.5% | -2646.3% | ||
| Q2 25 | -12.2% | -854.5% | ||
| Q1 25 | -27.5% | — | ||
| Q4 24 | 16.8% | -1725.0% | ||
| Q3 24 | 1.8% | -423.4% | ||
| Q2 24 | -22.4% | -330.0% | ||
| Q1 24 | -13.8% | — |
| Q4 25 | — | $2.60 | ||
| Q3 25 | — | $-3.58 | ||
| Q2 25 | — | $-0.70 | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-0.95 | ||
| Q3 24 | — | $-0.24 | ||
| Q2 24 | — | $-0.18 | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $2.4B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $3.8B |
| Total Assets | $461.5M | $6.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $2.4B | ||
| Q3 25 | $93.3M | $1.1B | ||
| Q2 25 | $75.5M | $546.9M | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | $340.3M | ||
| Q3 24 | $162.3M | $365.7M | ||
| Q2 24 | $177.9M | $369.8M | ||
| Q1 24 | $168.8M | — |
| Q4 25 | $341.7M | $3.8B | ||
| Q3 25 | $378.6M | $2.3B | ||
| Q2 25 | $377.6M | $1.2B | ||
| Q1 25 | $379.6M | — | ||
| Q4 24 | $395.7M | $383.9M | ||
| Q3 24 | $385.5M | $435.7M | ||
| Q2 24 | $389.1M | $463.3M | ||
| Q1 24 | $392.6M | — |
| Q4 25 | $461.5M | $6.6B | ||
| Q3 25 | $494.9M | $4.3B | ||
| Q2 25 | $493.3M | $1.3B | ||
| Q1 25 | $482.6M | — | ||
| Q4 24 | $499.5M | $508.4M | ||
| Q3 24 | $491.2M | $497.9M | ||
| Q2 24 | $483.7M | $517.4M | ||
| Q1 24 | $492.1M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $-74.5M |
| Free Cash FlowOCF − Capex | $-1.8M | $-83.3M |
| FCF MarginFCF / Revenue | -2.9% | -134.6% |
| Capex IntensityCapex / Revenue | 1.6% | 14.2% |
| Cash ConversionOCF / Net Profit | — | -0.10× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $-307.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $-74.5M | ||
| Q3 25 | $-3.9M | $-123.1M | ||
| Q2 25 | $108.0K | $-52.6M | ||
| Q1 25 | $-125.0K | — | ||
| Q4 24 | $2.0M | $-39.4M | ||
| Q3 24 | $13.2M | $-19.2M | ||
| Q2 24 | $6.2M | $-26.6M | ||
| Q1 24 | $4.0M | — |
| Q4 25 | $-1.8M | $-83.3M | ||
| Q3 25 | $-4.6M | $-127.2M | ||
| Q2 25 | $-1.5M | $-53.8M | ||
| Q1 25 | $-974.0K | — | ||
| Q4 24 | $1.1M | $-43.0M | ||
| Q3 24 | $12.2M | $-23.0M | ||
| Q2 24 | $5.2M | $-34.1M | ||
| Q1 24 | $3.4M | — |
| Q4 25 | -2.9% | -134.6% | ||
| Q3 25 | -8.7% | -319.1% | ||
| Q2 25 | -3.2% | -259.8% | ||
| Q1 25 | -2.3% | — | ||
| Q4 24 | 1.9% | -367.4% | ||
| Q3 24 | 23.7% | -185.3% | ||
| Q2 24 | 11.0% | -299.3% | ||
| Q1 24 | 7.6% | — |
| Q4 25 | 1.6% | 14.2% | ||
| Q3 25 | 1.3% | 10.4% | ||
| Q2 25 | 3.5% | 5.8% | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 1.6% | 30.7% | ||
| Q3 24 | 2.0% | 30.4% | ||
| Q2 24 | 2.3% | 65.8% | ||
| Q1 24 | 1.3% | — |
| Q4 25 | — | -0.10× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
IONQ
| Other | $31.2M | 50% |
| Platform Consulting And Support Services | $30.7M | 50% |
